Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious Leads
1. 系统已在2026-03-14 13:38:37对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1021/acs.jmedchem.1c01595
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01595
其他信息:
出版社: American Chemical Society (ACS)
作者: Mingzong Li; Zenon Konteatis; Nelamangala Nagaraja; Yue Chen; Shubao Zhou; Guangning Ma; Stefan Gross; Katya Marjon; Marc L. Hyer; Everton Mandley; Max Lein; Anil K. Padyana; Lei Jin; Shuilong Tong; Rachel Peters; Joshua Murtie; Jeremy Travins; Matthew Medeiros; Peng Liu; Victoria Frank; Evan T. Judd; Scott A. Biller; Kevin M. Marks; Zhihua Sui; Samuel K. Reznik

